Genetic Risk Factors for Hepatopulmonary Syndrome in Patients With Advanced Liver Disease

Gastroenterology

Volumn 139, Issue 1, 2010, Pages

  Roberts, Kari E ^a   Kawut, Steven M ^b   Krowka, Michael J ^c   Brown Jr , Robert S ^d   Trotter, James F ^e   Shah, Vijay ^c   Peter, Inga ^f   Tighiouart, Hocine ^a   Mitra, Nandita ^b   Handorf, Elizabeth ^b   Knowles, James A ^g   Zacks, Steven ^h   Fallon, Michael B ⁱ  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MAYO CLINIC   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Genetic Polymorphism; Portal Hypertension

Indexed keywords

CAVEOLIN 3; COLLAGEN TYPE 18; COLLAGEN TYPE 18ALPHA1; ENDOGLIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TIE 1 RECEPTOR; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; ANGIOGENESIS; ARTERIAL OXYGEN TENSION; ARTICLE; CASE CONTROL STUDY; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEPATOPULMONARY SYNDROME; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROBUBBLE; NUCLEOTIDE SEQUENCE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; UNINDEXED SEQUENCE;

EID: 77953891976     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.03.044     Document Type: Article

References (47)

1. Rodriguez-Roisin R., Krowka M.J., Herve P., et al. Pulmonary-hepatic vascular Disorders (PHD). Eur Respir J 24 (2004) 861-880
2. Fuhrmann V., Madl C., Mueller C., et al. Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 131 (2006) 69-75
3. Swanson K.L., Wiesner R.H., and Krowka M.J. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 41 (2005) 1122-1129
4. Fallon M.B., Krowka M.J., Brown R.S., et al. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology 135 (2008) 1168-1175
5. Krowka M.J. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Clin Chest Med 26 (2005) 587-597
6. Cremona G., Higenbottam T.W., Mayoral V., et al. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 8 (1995) 1883-1885
7. Zhang J., Ling Y., Luo B., et al. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 125 (2003) 1441-1451
8. Yol S., Erikoglu M., Toprak S.S., et al. The effects of serum estrogen levels on hypoxemia and blood nitric oxide levels in experimental hepatopulmonary syndrome. Hepatol Res 33 (2005) 7-13
9. Schenk P., Madl C., Rezaie-Majd S., et al. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med 133 (2000) 701-706
10. Gomez F.P., Barbera J.A., Roca J., et al. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology 43 (2006) 1084-1091
11. Lee J.S., Semela D., Iredale J., et al. Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?. Hepatology 45 (2007) 817-825
12. Schraufnagel D.E., Malik R., Goel V., et al. Lung capillary changes in hepatic cirrhosis in rats. Am J Physiol 272 (1997) L139-L147
13. Zhang J., Luo B., Tang L., et al. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology 136 (2009) 1070-1080
14. Fallon M.B.R., Roberts K.E., Krowka M.J., et al. A multi-center case-control study of genetic predictors for hepatopulmonary syndrome (HPS) (2007), American Association for the Study of Liver Diseases, Boston, MA
15. Lazaridis K.N., Frank J.W., Krowka M.J., et al. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 107 (1999) 262-267
16. Seldin M.F., Shigeta R., Villoslada P., et al. European population substructure: clustering of northern and southern populations. PLoS Genet 2 (2006) e143
17. Li Q., and Yu K. Improved correction for population stratification in genome-wide association studies by identifying hidden population structures. Genet Epidemiol 32 (2008) 215-226
18. Purcell S., Neale B., Todd-Brown K., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 (2007) 559-575
19. Barrett J.C., Fry B., Maller J., et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
20. Schaid D.J., Rowland C.M., Tines D.E., et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
21. Gauderman W.J., Murcray C., Gilliland F., et al. Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol 31 (2007) 383-395
22. Wang K., and Abbott D. A principal components regression approach to multilocus genetic association studies. Genet Epidemiol 32 (2008) 108-118
23. R Development Core Team. R: A language and environmental for statistical computing (2009), R Foundation for statistical computing, Vienna
24. Foulkes A.S. Applied statistical genetics with R (2009), Springer, New York
25. Breiman L. Random forests. Machine Learning 45 (2001) 5-32
26. Gauderman W., and Morrison J. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydra.usc.edu/gxe Accessed June 11, 2009
27. Klemm T., Mehnert A.K., Siegemund A., et al. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes 113 (2005) 568-572
28. Fallon M.B., Abrams G.A., Luo B., et al. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 113 (1997) 606-614
29. Degano B., Mittaine M., Herve P., et al. Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients. Eur Respir J 34 (2009) 138-144
30. Carter E.P., Hartsfield C.L., Miyazono M., et al. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 283 (2002) L346-L353
31. Luo B., Liu L., Tang L., et al. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 38 (2003) 556-563
32. O'Reilly M.S., Boehm T., Shing Y., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997) 277-285
33. Digtyar A.V., Pozdnyakova N.V., Feldman N.B., et al. Endostatin: current concepts about its biological role and mechanisms of action. Biochemistry (Mosc) 72 (2007) 235-246
34. McAllister K.A., Grogg K.M., Johnson D.W., et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8 (1994) 345-351
35. Johnson D.W., Berg J.N., Baldwin M.A., et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13 (1996) 189-195
36. Sabba C., Pasculli G., Lenato G.M., et al. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost 5 (2007) 1149-1157
37. Singh H., Milner C.S., Aguilar Hernandez M.M., et al. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases. Cell Signal 21 (2009) 1346-1350
38. Manalo D.J., Rowan A., Lavoie T., et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105 (2005) 659-669
39. Baek J.H., Liu Y.V., McDonald K.R., et al. Spermidine/spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1α. J Biol Chem 282 (2007) 23572-23580
40. Peng Z.G., Zhou M.Y., Huang Y., et al. Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1α. Oncogene 27 (2008) 839-847
41. Iwatsuki K., Tanaka K., Kaneko T., et al. Runx1 promotes angiogenesis by down-regulation of insulin-like growth factor-binding protein-3. Oncogene 24 (2005) 1129-1137
42. Suda T., and Takakura N. Role of hematopoietic stem cells in angiogenesis. Int J Hematol 74 (2001) 266-271
43. Ismail S., Sturrock A., Wu P., et al. NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{β}1 and insulin-like growth factor binding protein-3. Am J Physiol Lung Cell Mol Physiol 296 (2009) L489-L499
44. Rolla G., Brussino L., Colagrande P., et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology 26 (1997) 842-847
45. Arguedas M.R., Drake B.B., Kapoor A., et al. Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome. Gastroenterology 128 (2005) 328-333
46. Ling Y., Zhang J., Luo B., et al. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology 39 (2004) 1593-1602
47. Benjamini Y., and Yekutieli D. Quantitative trait Loci analysis using the false discovery rate. Genetics 171 (2005) 783-790